DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Oncology Homepage

MR could predict survival and treatment response for patients with brain metastasis May spare them life-threatening surgeries

Brainlab to become distributor of Elekta's stereotactic neurosurgery products in US Already the supplier in select European markets

New nanoparticle technology may replace MR for cancer detection Shows promise in preclinical study

Study finds bi-annual MR exams better option for young women with genetic risk Annual mammogram may not be necessary

Study finds tomosynthesis is ultimately less expensive than digital mammography Diagnosis-related costs need to be considered

California Proton Therapy Center re-launches California Protons Consists of new management and leadership and an expanded group of physicians

Community practices not abiding by breast cancer screening guidelines for MR High breast density isn't enough

Volpara brings quality control and better risk assessment to breast imaging Launches two new products as part of VolparaEnterprise platform at RSNA

Study finds Transpara deep learning CAD system performs as well as radiologists ScreenPoint solution provides cancer suspicion score from 0 to 100

Elekta delays order target for Unity MR linac Making 'difficult' short-term decisions to benefit long term

Based on one of largest studies
comparing digital and
conventional approaches

Philips IntelliSite Pathology Solution gets FDA clearance for primary diagnostic use

by Lauren Dubinsky , Senior Reporter
Royal Philips announced on Wednesday that the FDA cleared its Philips IntelliSite Pathology Solution (PIPS) for primary diagnostic use. It's the first whole-slide imaging system that can be used to review and interpret digital surgical pathology slide prepared from biopsied tissue.

"[PIPS] allows pathologists to simplify access to histopathology information and work more efficiently," Russ Granzow, general manager of Philips Digital Pathology Solution, told HCB News. "The pathologists will have the agility to view digital images and aim to extend collaboration with peers, with the aim of increasing diagnostic confidence."

Story Continues Below Advertisement

Ask Any Woman. She Wants a Better Breast Imaging Experience.

SoftVue Can Bring It. In today's healthcare environment, a positive patient experience is central in providing excellent patient care. This is where SoftVue comes in - click to read more>>>



As cancer becomes more prevalent, pathologists are under pressure to meet the demand. They have to work as efficiently and effectively as possible to analyze the complex data that's used to design personalized treatments.

PIPS is composed of an ultra-fast pathology slide scanner, an image management system and display monitor. It also comes with advanced software tools to manage the scanning, storage, presentation, reviewing and information sharing processes.

With this solution, pathologists can read tissue slides digitally to make a diagnosis, instead of using a conventional light microscope to look directly at the tissue sample mounted on a glass slide.

"Because the system digitizes slides that would otherwise be stored in physical files, it also provides a streamlined slide storage and retrieval system that may ultimately help make critical health information available to pathologists, other health care professionals and patients faster," Alberto Gutierrez, director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health, said in a statement.

The agency evaluated data from a clinical study that involved about 2,000 surgical pathology cases. It was one of the largest studies that directly compared the use of digital pathology to conventional optical microscopes.

Sixteen pathologists at Cleveland Clinic, University of Virginia, Miraca Life Sciences and Advanced Pathology Associates performed about 16,000 reads of the cases. The results showed that the diagnoses made using PIPS were comparable to those made using the conventional method.

Previously, PIPS was only approved by the FDA to be used as an aid to the pathologist when detecting HER2 expression in breast cancer. It's now been expanded for primary diagnostic use.

Digital pathology has been a major focus for Philips in recent years. In June 2016, the company acquired PathXL's digital pathology portfolio. More recently in March, they partnered with a developer of artificial intelligence technology for pathology called PathAI.

In the same month, Philips introduced new additions to its pathology solutions portfolio at the 2017 United States and Canadian Academy of Pathology Annual Meeting. That includes research applications called TissueMark and Xplore, and applications for semi-quantification of breast IHC markers.

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED